
Currently out of the existing stock ratings of Steve Frankel, 196 are a BUY (92.89%), 13 are a HOLD (6.16%), 2 are a SELL (0.95%).
Analyst Steve Frankel, currently employed at ROSENBLATT, has had 43.74% of price targets met with an average potential upside of 22.24%, reached in 155 days on average.
Steve Frankel has documented 420 price targets and ratings displayed on 12 stocks. The coverage is on Communication Services, Technology, Consumer Defensive sectors.
Most recent stock forecast was given on DLB, Dolby Laboratories.
Analyst best performing recommendations are on QUOT (QUOTIENT TECHNOLOGY).
The best stock recommendation documented was for UTI (UNIVERSAL TECHNICAL INSTITUTE) on 11/13/2023. The price target of $11 was fulfilled within 3 days with a profit of $1.61 (17.15%), with a performance score of 57.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Mar-2023
$27.05
$45
3 years 3 months 5 days ago
(15-Aug-2023)
0/2 (0%)
$0.48 (1.81%)
Hold Since 14-Nov-2018
$27
$30
3 years 3 months 10 days ago
(10-Aug-2023)
8/8 (100%)
$0.34 (1.28%)
49
Buy Since 15-Nov-2019
$27.05
$34
3 years 3 months 10 days ago
(10-Aug-2023)
8/11 (72.73%)
$0.39 (1.46%)
94
Buy Since 01-May-2019
$53
3 years 3 months 10 days ago
(10-Aug-2023)
2/5 (40%)
$25.36 (91.75%)
394
Hold Since 12-Jul-2022
$27
$28
3 years 3 months 10 days ago
(10-Aug-2023)
4/4 (100%)
$0.34 (1.28%)
86
Which stock is Steve Frankel most bullish on?
Which stock is Steve Frankel most reserved on?
What Year was the first public recommendation made by Steve Frankel?